Quantitative proteome profiling provides evidence of an activation of the complement cascade in ATTR amyloidosis

References

• Rowczenio D, Quarta CC, Fontana M, et al. Analysis of the TTR gene in the investigation of amyloidosis: a 25-year single UK center experience. Hum Mutat. 2019;40(1):90–96.
   PubMed Web of Science ®Google Scholar
• Hahn K, Urban P, Meliß RR, et al. Carpal tunnel syndrome and ATTR-amyloidosis. Handchir Mikrochir Plast Chir. 2018;50(5):329–334.
   PubMed Web of Science ®Google Scholar
• Fosbol EL, Rorth R, Leicht BP, et al. Association of carpal tunnel syndrome with amyloidosis, heart failure, and adverse cardiovascular outcomes. J Am Coll Cardiol. 2019;74(1):15–23.
   PubMed Web of Science ®Google Scholar
• Benson MD, Buxbaum JN, Eisenberg DS, et al. Amyloid nomenclature 2020: update and recommendations by the international society of amyloidosis (ISA) nomenclature committee. Amyloid. 2020;27(4):217–222.
   PubMed Web of Science ®Google Scholar
• Brambilla F, Lavatelli F, Di Silvestre D, et al. Shotgun protein profile of human adipose tissue and its changes in relation to systemic amyloidoses. J Proteome Res. 2013;12(12):5642–5655.
   PubMed Web of Science ®Google Scholar
• Kourelis TV, Dasari SS, Dispenzieri A, et al. A proteomic atlas of cardiac amyloid plaques. JACC Cardiooncol. 2020;2(4):632–643.
   PubMedGoogle Scholar
• Ancsin JB, Kisilevsky R. The heparin/heparan sulfate-binding site on apo-serum amyloid A. Implications for the therapeutic intervention of amyloidosis. J Biol Chem. 1999;274(11):7172–7181.
   PubMedGoogle Scholar
• Coker AR, Purvis A, Baker D, et al. Molecular chaperone properties of serum amyloid P component. FEBS Lett. 2000;473(2):199–202.
   PubMed Web of Science ®Google Scholar
• Kisilevsky R. The relation of proteoglycans, serum amyloid P and apo E to amyloidosis current status, 2000. Amyloid. 2000;7(1):23–25.
   PubMed Web of Science ®Google Scholar
• Lux A, Gottwald J, Behrens HM, et al. Complement 9 in amyloid deposits. Amyloid. 2021;28(3):199–208.
   PubMedGoogle Scholar
• Müller-Eberhard HJ. Complement. Annu Rev Biochem. 1969;38:389–414.
   PubMed Web of Science ®Google Scholar
• Tegla CA, Cudrici C, Patel S, et al. Membrane attack by complement: the assembly and biology of terminal complement complexes. Immunol Res. 2011;51(1):45–60.
   PubMed Web of Science ®Google Scholar
• Esser AF, Kolb WP, Podack ER, et al. Molecular reorganization of lipid bilayers by complement: a possible mechanism for membranolysis. Proc Natl Acad Sci USA. 1979;76(3):1410–1414.
   PubMed Web of Science ®Google Scholar
• Kolb WP, Haxby JA, Arroyave CM, et al. Molecular analysis of the membrane attack mechanism of complement. J Exp Med. 1972;135(3):549–566.
   PubMedGoogle Scholar
• Podack ER, Müller-Eberhard HJ, Horst H, et al. Membrane attach complex of complement (MAC): three-dimensional analysis of MAC-phospholipid vesicle recombinants. J Immunol. 1982;128(5):2353–2357.
   PubMed Web of Science ®Google Scholar
• Papadimitriou JC, Drachenberg CB, Shin ML, et al. Ultrastructural studies of complement mediated cell death: a biological reaction model to plasma membrane injury. Virchows Arch. 1994;424(6):677–685.
   PubMed Web of Science ®Google Scholar
• Dasari S, Theis JD, Vrana JA, et al. Amyloid typing by mass spectrometry in clinical practice: a comprehensive review of 16,175 samples. Mayo Clin Proc. 2020;95(9):1852–1864.
   PubMed Web of Science ®Google Scholar
• Vrana JA, Gamez JD, Madden BJ, et al. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood. 2009;114(24):4957–4959.
   PubMed Web of Science ®Google Scholar
• Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem. 1962;10(3):355–364.
   Web of Science ®Google Scholar
• Hahn K, Nilsson KPR, Hammarstrom P, et al. Establishing and validating the fluorescent amyloid ligand h-FTAA (heptamer formyl thiophene acetic acid) to identify transthyretin amyloid deposits in carpal tunnel syndrome. Amyloid. 2017;24(2):78–86.
   PubMed Web of Science ®Google Scholar
• Doellinger J, Schneider A, Hoeller M, et al. Sample preparation by easy extraction and digestion (SPEED) - a universal, rapid, and detergent-free protocol for proteomics based on acid extraction. Mol Cell Proteomics. 2020;19(1):209–222.
   PubMed Web of Science ®Google Scholar
• Tyanova S, Cox J. Perseus: a bioinformatics platform for integrative analysis of proteomics data in cancer research. In: von Stechow L, editor. Cancer systems biology: Methods and protocols. New York (NY): Springer New York; 2018. p. 133–148.
   Google Scholar
• Vizcaino JA, Deutsch EW, Wang R, et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol. 2014;32(3):223–226.
   PubMed Web of Science ®Google Scholar
• Dogan A. Classification of amyloidosis by mass spectrometry-based proteomics. Amyloid and related disorders surgical pathology and clinical correlations. Berlin/Heidelberg: Springer; 2012. p. 261–272.
   Google Scholar
• Vrana JA, Theis JD, Dasari S, et al. Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics. Haematologica. 2014;99(7):1239–1247.
   PubMed Web of Science ®Google Scholar
• Helder MR, Schaff HV, Nishimura RA, et al. Impact of incidental amyloidosis on the prognosis of patients with hypertrophic cardiomyopathy undergoing septal myectomy for left ventricular outflow tract obstruction. Am J Cardiol. 2014;114(9):1396–1399.
   PubMed Web of Science ®Google Scholar
• Maleszewski JJ, Murray DL, Dispenzieri A, et al. Relationship between monoclonal gammopathy and cardiac amyloid type. Cardiovasc Pathol. 2013;22(3):189–194.
   PubMed Web of Science ®Google Scholar
• Rezania K, Pytel P, Smit LJ, et al. Systemic transthyretin amyloidosis in a patient with bent spine syndrome. Amyloid. 2013;20(2):131–134.
   PubMed Web of Science ®Google Scholar
• Lavatelli F, Vrana JA. Proteomic typing of amyloid deposits in systemic amyloidoses. Amyloid. 2011;18(4):177–182.
   PubMed Web of Science ®Google Scholar
• Puffer RC, Spinner RJ, Bi H, et al. Fatal TTR amyloidosis with neuropathy from domino liver p.Val71Ala transplant. Neurol Genet. 2019;5(5):e351.
   PubMedGoogle Scholar
• Sethi S, Theis JD, Leung N, et al. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis. Clin J Am Soc Nephrol. 2010;5(12):2180–2187.
   PubMed Web of Science ®Google Scholar
• Sethi S, Vrana JA, Theis JD, et al. Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis. Kidney Int. 2012;82(2):226–234.
   PubMed Web of Science ®Google Scholar
• Sethi S, Vrana JA, Theis JD, et al. Mass spectrometry based proteomics in the diagnosis of kidney disease. Curr Opin Nephrol Hypertens. 2013;22(3):273–280.
   PubMedGoogle Scholar
• D'Souza A, Theis J, Quint P, et al. Exploring the amyloid proteome in immunoglobulin-derived lymph node amyloidosis using laser microdissection/tandem mass spectrometry. Am J Hematol. 2013;88(7):577–580.
   PubMedGoogle Scholar
• Wisniewski T, Drummond E. APOE-amyloid interaction: therapeutic targets. Neurobiol Dis. 2020;138:104784.
   PubMed Web of Science ®Google Scholar
• Lee KW, Lee DH, Son H, et al. Clusterin regulates transthyretin amyloidosis. Biochem Biophys Res Commun. 2009;388(2):256–260. 16
   PubMedGoogle Scholar
• Torres-Arancivia CM, Chang D, Hackett WE, et al. Glycosylation of serum clusterin in Wild-Type Transthyretin-Associated (ATTRwt) amyloidosis: a study of Disease-Associated compositional features using mass spectrometry analyses. Biochemistry. 2020;59(45):4367–4378.
   PubMedGoogle Scholar
• Gottwald J, Röcken C. The amyloid proteome: a systematic review and proposal of a protein classification system. Crit Rev Biochem Mol Biol. 2021;56(5):526–542.
   PubMed Web of Science ®Google Scholar
• Mollee P, Boros S, Loo D, et al. Implementation and evaluation of amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry. Clin Proteomics. 2016;13:30.
   PubMed Web of Science ®Google Scholar
• Sjoberg AP, Trouw LA, Blom AM. Complement activation and inhibition: a delicate balance. Trends Immunol. 2009;30(2):83–90.
   PubMed Web of Science ®Google Scholar
• Pepys MB. The pentraxins. Front Immunol. 2018;9(2382):2382.
   PubMedGoogle Scholar
• Krance SH, Wu CY, Zou Y, et al. The complement Cascade in Alzheimer's disease: a systematic review and meta-analysis. Mol Psychiatry. 2019.
   PubMedGoogle Scholar
• Dunkelberger JR, Song WC. Complement and its role in innate and adaptive immune responses. Cell Res. 2010;20(1):34–50.
   PubMed Web of Science ®Google Scholar
• Röcken C, Stix B, Brömme D, et al. A putative role for cathepsin K in degradation of AA and AL amyloidosis. Am J Pathol. 2001;158(3):1029–1038.
   PubMedGoogle Scholar
• Ricklin D, Hajishengallis G, Yang K, et al. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11(9):785–797.
   PubMed Web of Science ®Google Scholar
• Cserhalmi M, Papp A, Brandus B, et al. Regulation of regulators: role of the complement factor H-related proteins. Semin Immunol. 2019;45:101341.
   PubMed Web of Science ®Google Scholar
• Schartz ND, Tenner AJ. The good, the bad, and the opportunities of the complement system in neurodegenerative disease. J Neuroinflammation. 2020;17(1):354.
   PubMed Web of Science ®Google Scholar